Fonte: Biomarkers in Medicine. Unidade: ICB
Assuntos: FISIOLOGIA, EPIGÊNESE GENÉTICA, DIABETES MELLITUS, RESISTÊNCIA À INSULINA, METILAÇÃO DE DNA, HOMEOSTASE, MÚSCULO ESQUELÉTICO, MICRORNAS, FARMACOGENÉTICA, BIOMARCADORES
ABNT
ESTEVES, João Victor e YONAMINE, Caio Yogi e MACHADO, Ubiratan Fabres. SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus. Biomarkers in Medicine. Abingdon, OX: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.2217/bmm-2019-0481. Acesso em: 10 nov. 2024. , 2020APA
Esteves, J. V., Yonamine, C. Y., & Machado, U. F. (2020). SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus. Biomarkers in Medicine. Abingdon, OX: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.2217/bmm-2019-0481NLM
Esteves JV, Yonamine CY, Machado UF. SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus [Internet]. Biomarkers in Medicine. 2020 ; 14( 6): 413-416.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/bmm-2019-0481Vancouver
Esteves JV, Yonamine CY, Machado UF. SLC2A4 expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus [Internet]. Biomarkers in Medicine. 2020 ; 14( 6): 413-416.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/bmm-2019-0481